1
|
Chang Y, Liang Y, Wu H, Li L, Yang B, Jiang L, Ren Q, Pei X. Adaptive assessment based on fractional CBCT images for cervical cancer. J Appl Clin Med Phys 2024; 25:e14462. [PMID: 39072895 PMCID: PMC11466466 DOI: 10.1002/acm2.14462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2024] [Revised: 06/25/2024] [Accepted: 06/27/2024] [Indexed: 07/30/2024] Open
Abstract
PURPOSE Anatomical and other changes during radiotherapy will cause inaccuracy of dose distributions, therefore the expectation for online adaptive radiation therapy (ART) is high in effectively reducing uncertainties due to intra-variation. However, ART requires extensive time and effort. This study investigated an adaptive assessment workflow based on fractional cone-beam computed tomography (CBCT) images. METHODS Image registration, synthetic CT (sCT) generation, auto-segmentation, and dose calculation were implemented and integrated into ArcherQA Adaptive Check. The rigid registration was based on ITK open source. The deformable image registration (DIR) method was based on a 3D multistage registration network, and the sCT generation method was performed based on a 2D cycle-consistent adversarial network (CycleGAN). The auto-segmentation of organs at risk (OARs) on sCT images was finished by a deep learning-based auto-segmentation software, DeepViewer. The contours of targets were obtained by the structure-guided registration. Finally, the dose calculation was based on a GPU-based Monte Carlo (MC) dose code, ArcherQA. RESULTS The dice similarity coefficient (DSCs) were over 0.86 for target volumes and over 0.79 for OARs. The gamma pass rate of ArcherQA versus Eclipse treatment planning system was more than 99% at the 2%/2 mm criterion with a low-dose threshold of 10%. The time for the whole process was less than 3 min. The dosimetric results of ArcherQA Adaptive Check were consistent with the Ethos scheduled plan, which can effectively identify the fractions that need the implementation of the Ethos adaptive plan. CONCLUSION This study integrated AI-based technologies and GPU-based MC technology to evaluate the dose distributions using fractional CBCT images, demonstrating remarkably high efficiency and precision to support future ART processes.
Collapse
Affiliation(s)
- Yankui Chang
- School of Nuclear Science and TechnologyUniversity of Science and Technology of ChinaHefeiChina
| | - Yongguang Liang
- Department of Radiation OncologyChinese Academy of Medical Sciences, Peking Union Medical College HospitalBeijingChina
| | - Haotian Wu
- Anhui Wisdom Technology Company LimitedHefeiChina
| | - Lingyan Li
- Anhui Wisdom Technology Company LimitedHefeiChina
| | - Bo Yang
- Department of Radiation OncologyChinese Academy of Medical Sciences, Peking Union Medical College HospitalBeijingChina
| | - Lipeng Jiang
- Department of Radiation OncologyFirst Affiliated Hospital of Jinzhou Medical UniversityShenyangChina
| | - Qiang Ren
- Anhui Wisdom Technology Company LimitedHefeiChina
| | - Xi Pei
- School of Nuclear Science and TechnologyUniversity of Science and Technology of ChinaHefeiChina
- Anhui Wisdom Technology Company LimitedHefeiChina
| |
Collapse
|
2
|
Bosma LS, Hussein M, Jameson MG, Asghar S, Brock KK, McClelland JR, Poeta S, Yuen J, Zachiu C, Yeo AU. Tools and recommendations for commissioning and quality assurance of deformable image registration in radiotherapy. Phys Imaging Radiat Oncol 2024; 32:100647. [PMID: 39328928 PMCID: PMC11424976 DOI: 10.1016/j.phro.2024.100647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2024] [Revised: 09/09/2024] [Accepted: 09/10/2024] [Indexed: 09/28/2024] Open
Abstract
Multiple tools are available for commissioning and quality assurance of deformable image registration (DIR), each with their own advantages and disadvantages in the context of radiotherapy. The selection of appropriate tools should depend on the DIR application with its corresponding available input, desired output, and time requirement. Discussions were hosted by the ESTRO Physics Workshop 2021 on Commissioning and Quality Assurance for DIR in Radiotherapy. A consensus was reached on what requirements are needed for commissioning and quality assurance for different applications, and what combination of tools is associated with this. For commissioning, we recommend the target registration error of manually annotated anatomical landmarks or the distance-to-agreement of manually delineated contours to evaluate alignment. These should be supplemented by the distance to discordance and/or biomechanical criteria to evaluate consistency and plausibility. Digital phantoms can be useful to evaluate DIR for dose accumulation but are currently only available for a limited range of anatomies, image modalities and types of deformations. For quality assurance of DIR for contour propagation, we recommend at least a visual inspection of the registered image and contour. For quality assurance of DIR for warping quantitative information such as dose, Hounsfield units or positron emission tomography-data, we recommend visual inspection of the registered image together with image similarity to evaluate alignment, supplemented by an inspection of the Jacobian determinant or bending energy to evaluate plausibility, and by the dose (gradient) to evaluate relevance. We acknowledge that some of these metrics are still missing in currently available commercial solutions.
Collapse
Affiliation(s)
- Lando S Bosma
- Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Mohammad Hussein
- Metrology for Medical Physics Centre, National Physical Laboratory, Teddington, UK
| | - Michael G Jameson
- GenesisCare, Sydney, Australia
- School of Clinical Medicine, Medicine and Health, University of New South Wales, Sydney, Australia
| | | | - Kristy K Brock
- Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Jamie R McClelland
- Centre for Medical Image Computing and the Wellcome/EPSRC Centre for Interventional and Surgical Sciences, Dept. Medical Physics and Biomedical Engineering, University College London, London, UK
| | - Sara Poeta
- Medical Physics Department, Institut Jules Bordet - Université Libre de Bruxelles, Belgium
| | - Johnson Yuen
- School of Clinical Medicine, Medicine and Health, University of New South Wales, Sydney, Australia
- St. George Hospital Cancer Care Centre, Sydney NSW2217, Australia
- Ingham Institute for Applied Medical Research, Sydney, Australia
| | - Cornel Zachiu
- Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Adam U Yeo
- Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
- The Sir Peter MacCallum Department of Oncology, the University of Melbourne, Melbourne, VIC, Australia
| |
Collapse
|
3
|
Wu X, Amstutz F, Weber DC, Unkelbach J, Lomax AJ, Zhang Y. Patient-specific quality assurance for deformable IMRT/IMPT dose accumulation: Proposition and validation of energy conservation based validation criterion. Med Phys 2023; 50:7130-7138. [PMID: 37345380 DOI: 10.1002/mp.16564] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2023] [Revised: 04/17/2023] [Accepted: 06/05/2023] [Indexed: 06/23/2023] Open
Abstract
BACKGROUND Deformable image registration (DIR)-based dose accumulation (DDA) is regularly used in adaptive radiotherapy research. However, the applicability and reliability of DDA for direct clinical usage are still being debated. One primary concern is the validity of DDA, particularly for scenarios with substantial anatomical changes, for which energy-conservation problems were observed in conceptual studies. PURPOSE We present and validate an energy-conservation (EC)-based DDA validation workflow and further investigate its usefulness for actual patient data, specifically for lung cancer cases. METHODS For five non-small cell lung cancer (NSCLC) patients, DDA based on five selective DIR methods were calculated for five different treatment plans, which include one intensity-modulated photon therapy (IMRT), two intensity-modulated proton therapy (IMPT), and two combined proton-photon therapy (CPPT) plans. All plans were optimized on the planning CT (planCT) acquired in deep inspiration breath-hold (DIBH) and were re-optimized on the repeated DIBH CTs of three later fractions. The resulting fractional doses were warped back to the planCT using each DIR. An EC-based validation of the accumulation process was implemented and applied to all DDA results. Correlations between relative organ mass/volume variations and the extent of EC violation were then studied using Bayesian linear regression (BLR). RESULTS For most OARs, EC violation within 10% is observed. However, for the PTVs and GTVs with substantial regression, severe overestimation of the fractional energy was found regardless of treatment type and applied DIR method. BLR results show that EC violation is linearly correlated to the relative mass variation (R^2 > 0.95) and volume variation (R^2 > 0.60). CONCLUSION DDA results should be used with caution in regions with high mass/volume variation for intensity-based DIRs. EC-based validation is a useful approach to provide patient-specific quality assurance of the validity of DDA in radiotherapy.
Collapse
Affiliation(s)
- Xin Wu
- Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
- Department of Information Technology & Electrical Engineering, ETH Zurich, Zurich, Switzerland
| | - Florian Amstutz
- Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
- Department of Physics, ETH Zurich, Zurich, Switzerland
| | - Damien C Weber
- Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
- Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
- Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Jan Unkelbach
- Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
| | - Antony J Lomax
- Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
- Department of Physics, ETH Zurich, Zurich, Switzerland
| | - Ye Zhang
- Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
| |
Collapse
|
4
|
Lowther N, Louwe R, Yuen J, Hardcastle N, Yeo A, Jameson M. MIRSIG position paper: the use of image registration and fusion algorithms in radiotherapy. Phys Eng Sci Med 2022; 45:421-428. [PMID: 35522369 PMCID: PMC9239966 DOI: 10.1007/s13246-022-01125-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/28/2022] [Indexed: 12/12/2022]
Abstract
The report of the American Association of Physicists in Medicine (AAPM) Task Group No. 132 published in 2017 reviewed rigid image registration and deformable image registration (DIR) approaches and solutions to provide recommendations for quality assurance and quality control of clinical image registration and fusion techniques in radiotherapy. However, that report did not include the use of DIR for advanced applications such as dose warping or warping of other matrices of interest. Considering that DIR warping tools are now readily available, discussions were hosted by the Medical Image Registration Special Interest Group (MIRSIG) of the Australasian College of Physical Scientists & Engineers in Medicine in 2018 to form a consensus on best practice guidelines. This position statement authored by MIRSIG endorses the recommendations of the report of AAPM task group 132 and expands on the best practice advice from the 'Deforming to Best Practice' MIRSIG publication to provide guidelines on the use of DIR for advanced applications.
Collapse
Affiliation(s)
- Nicholas Lowther
- Department of Radiation Oncology, Wellington Blood and Cancer Centre, Wellington, New Zealand
| | - Rob Louwe
- Holland Proton Therapy Centre, Delft, Netherlands
| | - Johnson Yuen
- St George Hospital Cancer Care Centre, Kogarah, New South Wales, 2217, Australia
- South Western Clinical School, University of New South Wales, Sydney, Australia
- Ingham Institute for Applied Medical Research, Sydney, NSW, Australia
| | - Nicholas Hardcastle
- Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia
- The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia
| | - Adam Yeo
- Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
- School of Applied Sciences, RMIT University, Melbourne, VIC, Australia
| | - Michael Jameson
- GenesisCare, Sydney, NSW, 2015, Australia.
- St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
| |
Collapse
|
5
|
Lowther NJ, Marsh SH, Louwe RJ. Dose accumulation to assess the validity of treatment plans with reduced margins in radiotherapy of head and neck cancer. Phys Imaging Radiat Oncol 2020; 14:53-60. [PMID: 33458315 PMCID: PMC7807697 DOI: 10.1016/j.phro.2020.05.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2020] [Revised: 04/25/2020] [Accepted: 05/15/2020] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND AND PURPOSE Literature has reported reduced treatment toxicity in head-and-neck radiotherapy (HNRT) when reducing the planning target volume (PTV) margin from 5 to 3 mm but loco-regional control was not always preserved. This study used deformable image registration (DIR)-facilitated dose accumulation to assess clinical target volume (CTV) coverage in the presence of anatomical changes. MATERIALS AND METHODS VMAT plans for 12 patients were optimized using 3 or 5 mm PTV and planning risk volume (PRV) margins. The planning computed tomography (pCT) scan was registered to each daily cone beam CT (CBCT) using DIR. The inverse registration was used to reconstruct and accumulate dose (D acc ). CTV coverage was assessed using the dose-volume histogram (DVH) metric D 99 % acc and by individual voxel analysis. Both approaches included an uncertainty estimate using the 95% level of confidence. RESULTS D 99 % acc was less than 95% of the prescribed doseD presc for three cases including only one case where this was at the 95% level of confidence. However for many patients, the accumulated dose included a substantial volume of voxels receiving less than 95%D presc independent of margin expansion, which predominantly occurred in the subdermal region. Loss in target coverage was very patient specific but tightness of target volume coverage at planning was a common factor leading to underdosage. CONCLUSION This study agrees with previous literature that PTV/PRV margin reduction did not significantly reduce CTV coverage during treatment, but also highlighted that tight coverage of target volumes at planning increases the risk of clinically unacceptable dose delivery. Patient-specific verification of dose delivery to assess the dose delivered to each voxel is recommended.
Collapse
Affiliation(s)
- Nicholas J. Lowther
- Wellington Blood and Cancer Centre, Department of Radiation Oncology, Wellington, New Zealand
- University of Canterbury, School of Physical and Chemical Sciences, Christchurch, New Zealand
| | - Steven H. Marsh
- University of Canterbury, School of Physical and Chemical Sciences, Christchurch, New Zealand
| | - Robert J.W. Louwe
- Wellington Blood and Cancer Centre, Department of Radiation Oncology, Wellington, New Zealand
| |
Collapse
|
6
|
Lowther NJ, Marsh SH, Louwe RJW. Quantifying the dose accumulation uncertainty after deformable image registration in head-and-neck radiotherapy. Radiother Oncol 2020; 143:117-125. [PMID: 32063377 DOI: 10.1016/j.radonc.2019.12.009] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2019] [Revised: 12/12/2019] [Accepted: 12/15/2019] [Indexed: 11/26/2022]
Abstract
BACKGROUND AND PURPOSE Deformable image registration (DIR) facilitated dose reconstruction and accumulation can be applied to assess delivered dose and verify the validity of the treatment plan during treatment. This retrospective study used in silico deformations based on clinically observed anatomical changes as ground truth to investigate the uncertainty of reconstructed and accumulated dose in head-and-neck radiotherapy (HNRT). MATERIALS AND METHODS A planning CT (pCT), cone beam CT (CBCT) from week one of treatment and three later CBCTs were selected for 12 HNRT patients. These images were used to generate in silico reference CBCTs and deformation vector fields (DVFs) as ground truth with B-spline DIR. Inverse consistency (IC) of voxels was assessed by determining their net displacement after successive application of the forward and backward DVF. The reconstructed dose based on demons DIR was compared to the ground truth to assess the structure-specific uncertainties of this DIR algorithm for inverse consistent and inverse inconsistent voxels. RESULTS Overall, 98.5% of voxels were inverse consistent with the 95% level of confidence range for dose reconstruction of a single fraction equal to [-2.3%; +2.1%], [-10.2%; +15.2%] and [-9.5%; +12.5%] relative to their planned dose for target structures, critical organs at risk (OARs) and non-critical OARs, respectively. Inverse inconsistent voxels generally showed a higher level of uncertainty. CONCLUSION The uncertainty in accumulated dose using DIR can be accurately quantified and incorporated in dose-volume histograms (DVHs). This method can be used to prospectively assess the adequacy of target coverage during treatment in an objective manner.
Collapse
Affiliation(s)
- Nicholas J Lowther
- Wellington Blood and Cancer Centre, Department of Radiation Oncology, Wellington, New Zealand; University of Canterbury, School of Physical and Chemical Sciences, Christchurch, New Zealand
| | - Steven H Marsh
- University of Canterbury, School of Physical and Chemical Sciences, Christchurch, New Zealand
| | - Robert J W Louwe
- Wellington Blood and Cancer Centre, Department of Radiation Oncology, Wellington, New Zealand.
| |
Collapse
|
7
|
Abstract
As deformable image registration makes its way into the clinical routine, the summation of doses from fractionated treatment regimens to evaluate cumulative doses to targets and healthy tissues is also becoming a frequently utilized tool in the context of image-guided adaptive radiotherapy. Accounting for daily geometric changes using deformable image registration and dose accumulation potentially enables a better understanding of dose-volume-effect relationships, with the goal of translation of this knowledge to personalization of treatment, to further enhance treatment outcomes. Treatment adaptation involving image deformation requires patient-specific quality assurance of the image registration and dose accumulation processes, to ensure that uncertainties in the 3D dose distributions are identified and appreciated from a clinical relevance perspective. While much research has been devoted to identifying and managing the uncertainties associated with deformable image registration and dose accumulation approaches, there are still many unanswered questions. Here, we provide a review of current deformable image registration and dose accumulation techniques, and related clinical application. We also discuss salient issues that need to be deliberated when applying deformable algorithms for dose mapping and accumulation in the context of adaptive radiotherapy and response assessment.
Collapse
|
8
|
Green OL, Henke LE, Hugo GD. Practical Clinical Workflows for Online and Offline Adaptive Radiation Therapy. Semin Radiat Oncol 2019; 29:219-227. [PMID: 31027639 DOI: 10.1016/j.semradonc.2019.02.004] [Citation(s) in RCA: 83] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Adaptive radiotherapy emerged over 20 years ago and is now an established clinical practice in a number of organ sites. No one solution for adaptive therapy exists. Rather, adaptive radiotherapy is a process which combines multiple tools for imaging, assessment of need for adaptation, treatment planning, and quality assurance of this process. Workflow is therefore a critical aspect to ensure safe, effective, and efficient implementation of adaptive radiotherapy. In this work, we discuss the tools for online and offline adaptive radiotherapy and introduce workflow concepts for these types of adaptive radiotherapy. Common themes and differences between the workflows are introduced and controversies and areas of active research are discussed.
Collapse
Affiliation(s)
- Olga L Green
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO
| | - Lauren E Henke
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO
| | - Geoffrey D Hugo
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO.
| |
Collapse
|
9
|
|